byiShook Opinion
Jan 21, 2025 - 12:40
Guardant Health stock hit a 13-month high Tuesday after Medicare officials agreed to pay for the company's colon cancer blood test. The post Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone appeared first on Investor's Business Daily.
Guardant Health stock hit a 13-month high Tuesday after Medicare officials agreed to pay for the company's colon cancer blood test.
The post Why Top 4% Guardant Health Surged To A 13-Month High And Topped A Profit-Taking Zone appeared first on Investor's Business Daily.